Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 1Terminated 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Osteosarcoma 4Sarcoma 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Recurrence 2Cardiotoxicity 2Breast Neoplasms 2Sezary Syndrome 1Sarcoma, Ewing 1Neuroectodermal Tumors, Primitive, Peripheral 1Mycosis Fungoides 1Lymphoma, T-Cell, Peripheral 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Extranodal NK-T-Cell 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia, Hairy Cell 1Leukemia, Biphenotypic, Acute 1Leukemia 1Intraocular Lymphoma 1Inflammatory Breast Neoplasms 1Immunoblastic Lymphadenopathy 1Hypersensitivity 1Dendritic Cell Sarcoma, Interdigitating 1Burkitt Lymphoma 1Blast Crisis 1

Interventions

Ifosfamide 3Etoposide 3Thiotepa 2Stem Cell Transplantation 2Radiotherapy 2Melphalan 2Irinotecan 2Filgrastim 2thymoglobulin 1temsirolimus 1sargramostim 1robatumumab 1omburtamab I-131 1fludarabine phosphate 1etoposide phosphate 1Valproic Acid 1Temozolomide 1Tacrolimus 1Radiotherapy, Intensity-Modulated 1Radiosurgery 1Neoadjuvant Therapy 1Mycophenolic Acid 1Microarray Analysis 1Mesna 1Immunohistochemistry 1Immunoenzyme Techniques 1Granulocyte Colony-Stimulating Factor 1FANG vaccine 1Doxorubicin 1Dexrazoxane 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Neuroectodermal Tumors, Primitive, Peripheral × Dexrazoxane × Clear all
NCT00544778 2014-08-28

Combination Chemotherapy and Dexrazoxane Followed by Surgery and Radiation Therapy in Treating Patients With Advanced Soft Tissue Sarcoma or Recurrent Bone Sarcoma

City of Hope Medical Center

Phase 2 Terminated
7 enrolled 2 charts
Sarcoma

Sarcoma, Osteosarcoma, Neuroectodermal Tumors, Primitive, Peripheral

Data powered by HemOnc (CC BY 4.0) Colophon âš¡